MediWound (MDWD) Accounts Payables (2013 - 2026)
MediWound (MDWD) posted Accounts Payables of $7.6 million for Q2 2026, up 2.94% on a QoQ basis from $7.4 million in Q1 2026, and up 29.69% year-over-year from $5.9 million in Q2 2025.
Analysis
MediWound (MDWD) Accounts Payables (2013 - 2026) Analysis & Trends
MediWound has reported Accounts Payables for 14 years, with the latest figure at $7.6 million in Q2 2026.
- On a quarterly basis, Accounts Payables rose 29.69% year-over-year to $7.6 million in Q2 2026; TTM through Jun 2026 was $7.6 million, a 29.69% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, up 44.82% from the prior year.
- Accounts Payables was $7.6 million for Q2 2026 at MediWound, up from $7.4 million in the prior quarter.
- The five-year high for Accounts Payables was $8.5 million in Q3 2025, with the low at $2.7 million in Q2 2024.
- Average Accounts Payables over 5 years is $5.2 million, with a median of $5.1 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables tumbled 39.48% in 2023, then soared 171.8% in 2025.
- Over 5 years, Accounts Payables stood at $5.7 million in 2022, then retreated by 2.26% to $5.5 million in 2023, then dropped by 4.47% to $5.3 million in 2024, then jumped by 44.82% to $7.6 million in 2025, then dropped by 0.29% to $7.6 million in 2026.
- The last three Accounts Payables figures came in at $7.6 million (Q2 2026), $7.4 million (Q1 2026), and $7.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 7.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.63 Mn |
| Mar 31, 2026 | 7.41 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 8.51 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 5.66 Mn |
| Sep 30, 2022 | 3.57 Mn |
| Jun 30, 2022 | 4.88 Mn |
| Mar 31, 2022 | 5.62 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 3.71 Mn |